Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oppenheimer Downgrades BioCryst Pharmaceuticals to Perform

Oppenheimer Downgrades BioCryst Pharmaceuticals to Perform

Oppenheimer analyst Justin Kim downgrades BioCryst Pharmaceuticals (NASDAQ:BCRX) from Outperform to Perform.

byBenzinga Newsdesk

August 5, 2022

1 minute read

Oppenheimer analyst Justin Kim downgrades BioCryst Pharmaceuticals (NASDAQ:BCRX) from Outperform to Perform.

FuboTV Stock Is Trading Down Today: What’s Going On?

By Adam Eckert

February 27, 10:54 AM

FuboTV Inc (NYSE: FUBO) shares are plunging Monday morning after the company reported better-than-expected financial results.

FUBO

Ceridian Analyst Boosts Price Target By 19% Citing Resilient HCM Performance

By Anusuya Lahiri

October 31, 1:08 PM

Barclays analyst Raimo Lenschow upgraded Ceridian HCM Holding Inc (NYSE:CDAY) from Underweight to Equal-Weight and raised the price target from $54 to…

CDAY

Is It All About AI Now For Elon Musk?

By Jose Rodrigo Safdiye

March 3, 2:57 PM

It's no secret that ChatGPT is the talk of the town. Its technology has opened up countless doors and possibilities for the world of business, finance and education, with artificial intelligence being a technology that impacts absolutely everything.

$DOGE